No shortage of HIV drug Dolutegravir: Mandaviya


New Delhi, Aug 1 (IANS): Union Health and Family Welfare Minister Mansukh Mandaviya on Tuesday told the Parliament that there is no nation-wide shortage of HIV drug Dolutegravir.

His assurence came in response to a question in Rajya Sabha on whether there is a nation-wide shortage of the valuable HIV drug.

Dolutegravir (DTG) was introduced under the National AIDS Control Programme (NACP) in a phased manner in 2020, he said, adding that various proactive steps have been undertaken to ensure uninterrupted supply of antiretroviral (ARV) medicines including Dolutegravir.

In response to another question, Mandaviya said: "The MoHFW has developed a telemedicine application eSanjeevani, which provides doctor to doctor and patient to doctor consultations.

"This application works on a hub and spoke model wherein doctors including specialists provide services to patients in Health and Wellness Centers (HWCs) in rural areas. Further people in remote and rural areas can also avail services through OPD module of eSanjeevani."

As on July 26 July, a total of 14,17,81,384 teleconsultations have been completed, Mandaviya added.

 

  

Top Stories


Leave a Comment

Title: No shortage of HIV drug Dolutegravir: Mandaviya



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.